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Syndromic surveillance is a novel automated approach to monitoring inﬂuenza activity, but there is no
consensus regarding the most informative data sources for use within such a system. By comparing phy-
sician billing data from Quebec, Canada and hospital admission records, we assessed the timeliness of
medical visits for inﬂuenza-like illnesses (ILI) to two types of outpatient healthcare settings. Overall,
ILI visits by children aged 5–17 years at community-based settings were the most strongly correlated
with hospital admissions and gave the greatest lead over hospital admissions. However, a degree of
year-to-year variation suggests that syndromic surveillance of inﬂuenza should not focus on just a single
subgroup. These ﬁndings reveal the richness of these real-time data for epidemic monitoring and dem-
onstrate the ﬂexibility of syndromic surveillance. By using real-time data, an evolving epidemic can be
rapidly characterized by its epidemiological patterns, which is not possible with traditional surveillance
systems.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Inﬂuenza is an infectious respiratory disease with an annual
epidemic cycle associated with high mortality among the elderly
[1,2], hospitalizations among both the elderly and the very young
[1–3], and substantial economic consequences [4]. Recent epidem-
ics of emerging infectious diseases such as SARS, avian inﬂuenza,
and most recently, A/H1N1 ‘‘swine’’ inﬂuenza have stressed the
need for better disease surveillance systems to enable prompt
detection and aid the subsequent public health response.
Syndromic surveillance is a novel approach for monitoring dis-
ease occurrence. It relies on advanced statistical and computa-
tional methods to continuously monitor data that are collected
automatically from clinical and other non-traditional settings in
real-time or near real-time [5]. Since pre-diagnostic data are used,
syndromic surveillance can provide an earlier indication of anll rights reserved.
unization Practices; ARIMA,
ss-correlation function; CDC,
ergency department; ICD-9,
n; ILI, inﬂuenza-like illness;
surance Maladie du Québec;
ue West, Montreal, Quebec,
uckeridge).outbreak than traditional laboratory or sentinel physician based
surveillance [6]. Moreover, given the demographic data available
from clinical sources, syndromic surveillance allows public health
departments to monitor evolving patterns of illness among popu-
lation subgroups, ﬂexibly adjusting their focus as a situation
emerges [7]. Several syndromic surveillance systems are described
in the literature [8–11], and according to a survey, 89% of state, ter-
ritorial and local public health departments in the United States
perform syndromic surveillance [12]. Most systems follow data
from emergency departments (ED) but there is little empirical evi-
dence regarding the most informative data sources to monitor.
Although analyses of administrative data suggest that children
are sentinels of an inﬂuenza epidemic in the population [2,13–
15], there is debate concerning the speciﬁc age-groups that present
earliest and provide the strongest indication of a rise in inﬂuenza
activity. It is also not clear which setting provides the earliest sig-
nal as most studies have examined ED data [14–16] and few
researchers have compared the timing of signals from visits to
EDs to signals from visits to other settings such as community-
based settings including private ofﬁces and community clinics.
Each inﬂuenza season can also be quite different due to the con-
stant evolution of the inﬂuenza virus. The introduction of a new
antigenic strain often leads to increased morbidity and healthcare
utilization, as was the case with the B/Hong Kong/330/01 strain
that spread to North America during the 2001–2002 season after
a decade-long absence of the B/Victoria lineage on that continent
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season after a 20 year global absence of A/H1N1 strains [17]. We
suspected that annual differences in the healthcare utilization in
a population may also modify the ability of a surveillance system
to detect epidemic signals.
In this study, using physician billing data from Quebec, Canada,
we sought to clarify the timing of visits for inﬂuenza-like illnesses
(ILI) by age-group and setting, and to explore year-to-year varia-
tions in these patterns. Simultaneously, we also aimed to explore
the utility of physician billing data from outpatient settings for
automated syndromic surveillance of ILI.2. Methods
2.1. Overview and study design
For our study period from January 4, 1998, to December 27,
2003 (inclusive), we compared the timing of age-restricted subsets
of fee-for-service medical billing claims with ILI diagnoses from
community-based care settings and hospital EDs (as a measure of
ILI visits) to hospitalizations for P&I (as a robust measure of inﬂu-
enza circulation) in Quebec, Canada. In the ﬁrst stage of our study,
we examined overall patterns by including all weeks in our study
period in a single analysis. In the second stage, we examined
year-to-year variations by repeating separate analyses for each
individual inﬂuenza epidemic period.
2.2. Context
The Régie de l’Assurance Maladie du Québec (RAMQ) is the
agency responsible for the health insurance program in the prov-
ince of Quebec. Ninety-nine percent of all Quebec residents are
covered for the cost of hospital and physician services under this
program, and of all medical visits billed to RAMQ, 85–95% are
billed on a fee-for-service basis [18].
2.3. Data sources
2.3.1. Viral isolates data
Viral testing data were obtained from the Laboratoire de Santé
Publique du Québec (Quebec Public Health Laboratory). These data
included weekly counts of the results of three types of diagnostic
tests for inﬂuenza (culture, antigen-detection, and polymerase
chain reaction).
2.3.2. Fee-for-service billing claims data
In a previous study, we identiﬁed a set of 3424 new physi-
cians who were licensed to practice in Ontario and/or Quebec,
and then requested that RAMQ identify all patients seen by
these physicians from 1993 through 2003 and provide us the
fee-for-service billing claims submitted for these patients by
any physician in Quebec (whether or not part of the set of study
physicians) during this period [19]. Therefore, we had complete
ascertainment of healthcare delivered on a fee-for-service basis
for this cohort of patients. Each billing claim contains informa-
tion such as anonymized unique identiﬁers for the physician
and patient, an International Classiﬁcation of Diseases, Ninth
Revision (ICD-9) diagnostic code, a code for the setting type,
and the date of the visit.
2.3.3. Hospitalization data
Our hospitalization data from the Quebec hospitalization data-
base (MED-ECHO) captured all hospitalizations in Quebec. These
records included the date of admission, date of discharge, and
the discharge diagnosis.2.4. Study population
We identiﬁed all physicians as ‘‘in practice’’ in the fee-for-ser-
vice system by 1998 if they had at least one billing claim among
our fee-for-service data from 1993 through 1997. The study popu-
lation included all patients seen by these physicians from 1998
through 2003. Our study population in each year of our study per-
iod represented approximately 35–36% of the total source popula-
tion of all RAMQ beneﬁciaries that had received at least one
medical service in the same year [20]. Except for a slight overrep-
resentation of the elderly and females in our patient population, it
was otherwise similar to the total RAMQ population by age and sex
distributions.
2.5. Outcome measures
2.5.1. Epidemic period deﬁnition
Epidemic periods (see Table A-1 in Appendix A for details) were
identiﬁed using viral isolates data, the gold standard for viral circu-
lation. We pooled the results of the three diagnostic tests together
and deﬁned the start of each epidemic period as 4 weeks before the
ﬁrst two consecutive weeks during which the total number of po-
sitive specimens (for either inﬂuenza A or B) was ﬁve or more. We
shifted the start week back to accommodate both our expectation
that an increase in positive viral tests will be preceded by an in-
crease in ILI visits, as well as the fact that we would later be shift-
ing the time series in the cross-correlation function (CCF)
computation. The end week was deﬁned as the week before two
consecutive weeks during which the total count was under ﬁve.
2.5.2. Medical visits for inﬂuenza-like illnesses (ILI)
A medical visit was considered an ILI visit if it resulted in at
least one fee-for-service billing claim with an ICD-9 diagnostic
code from the code set provided in Table A-2 in Appendix A. We
constructed time series of the weekly number of ILI visits for each
age-group and for each of two types of outpatient settings: (1)
community-based care setting (including private ofﬁces, private
clinics, and local community health and social services centers),
and (2) hospital ED. We excluded hospital-based outpatient clinics
from community-based care settings because they tend to see only
referrals and cater to a different patient population compared to
other community-based care settings in Quebec. During a single
medical visit, a physician may perform multiple services, each of
which would be billed for separately. To reduce overcounting of
distinct visits, we aggregated billing claims such that each unique
patient was counted no more than once per day in each time series.
2.5.3. Pneumonia and inﬂuenza (P&I) hospitalizations
We generated a time series of the number of short-term hospi-
talizations per week in all of Quebec with a primary discharge
diagnosis of P&I (ICD-9 codes 480–487) to serve as a common ref-
erence against which the time series of ILI visits would be com-
pared. P&I hospitalizations data are a commonly used measure
for tracking and measuring the impact of inﬂuenza [21,22] because
they provide a sensitive and representative measure of the burden
of inﬂuenza morbidity [23,24].
2.6. Data analysis
Note: For a more detailed explanation of the statistical methods
that were used, please see Appendix B (technical appendix).
2.6.1. Accounting for autocorrelation with ARIMA modeling
We ﬁrst used Box and Jenkins seasonal autoregressive inte-
grated moving average (ARIMA) models [25,26] to model the auto-
correlation structure within each age-group and setting speciﬁc ILI
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for the effects of winter and non-winter holidays (listed in Table A-
3 in Appendix A). For each time series, we assessed the adequacy of
several candidate models using diagnostic criteria that test for the
presence of autocorrelation in the residuals. The Akaike Informa-
tion Criterion [26] was used to help choose between the models
deemed adequate.2.6.2. Analysis of timeliness and correlation through the cross-
correlation function (CCF)
After ﬁnding ARIMA models for each subset of the ILI visits time
series as described above, we applied the same model to the P&I
hospitalizations reference time series. We then computed the
cross-correlation function (CCF) at lags up to ±4 weeks between
the residuals for each subpopulation’s ILI visits time series and
the residuals for the P&I hospitalizations time series (serving as a
common reference series). In the ﬁrst stage of our study, we pro-
duced one CCF using residuals for all weeks in our study period.
However, in the second stage, we produced a separate CCF for each
inﬂuenza epidemic period during our study period, and using only
the residuals corresponding to epidemic weeks for each period. By
applying ARIMAmodeling and then using the residuals, we worked
with a ﬁltered time series in which the autocorrelation structure
has been removed. Failure to account for temporal autocorrelation
before correlating two time series can result in high correlations
even when a true relationship between the variables does not exist
[26–28]. To assess timeliness, we noted the lags in the CCF at
which the maximum correlation and other signiﬁcant correlations
occurred to determine the lead-time of one series relative to the
other. Signiﬁcance was assessed by constructing the 95% conﬁ-
dence interval about a correlation of zero (calculated using Fisher’s
transformation). We also created ‘‘heat-maps’’ of these CCFs, in
which the degree of correlation was represented by a color
gradient after being standardized (to each subpopulation) by cen-
tering and then scaling (i.e. dividing by their root-mean-square).0
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Fig. 1. Time series plots of the weekly total counts of inﬂuenza-like illness (ILI) visits to co
and inﬂuenza (P&I) hospitalizations. Shaded regions indicate sustained periods of positiStatistical analyses were performed using the R statistical soft-
ware (version 2.6.2; R Foundation for Statistical Computing, Vien-
na, Austria). Institutional Review Board approval was granted by
McGill University, Faculty of Medicine.3. Results
3.1. Descriptive statistics
From 1998 through 2003, there were a total of 2541,926 unique
study patients with at least one billing claim from a community-
based healthcare setting or a hospital ED in Quebec. Collectively,
they made a total of 73,091,025 visits during the study period,
7% of which were given an ILI diagnosis (Fig. 1). There were higher
proportions of females and young children among those diagnosed
with ILI at least once during this period compared to the total study
patient population (please see Table A-4 in Appendix A). During
the same period, there were 104,571 short-term hospitalizations
across Quebec with a primary diagnosis of P&I. The proportion of
visits due to ILI was approximately the same (7%) among both
community-based care settings and hospital EDs, although the
majority of the ILI visits were to community settings (83%) as op-
posed to the ED (17%). A larger proportion of the ILI visits to com-
munity-based settings were from working-aged adults, while the
elderly and the youngest children made up a greater share of ILI
visits in emergency departments (Table 1).3.2. Timeliness and correlation
For each cross-correlation function (CCF) between each subpop-
ulation’s ILI visits series and the P&I hospitalizations, Table 2
shows the lag at which the maximum correlation, as well as the
greatest lag at which a signiﬁcant correlation were found for our
overall analysis using data from all weeks of the study period.
Table 3 shows selected subsets for the year-to-year analysis. SeeApr Jul Oct Jan Apr Jul Oct Jan Apr Jul Oct
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mmunity-based care settings and hospital emergency departments, and pneumonia
ve viral cultures (inﬂuenza A or B).
Table 1
Age-group breakdown of medical visits for ILI by study patients during 1998–2003 in
Quebec, Canada at two types of outpatient settings.
Age-group Proportion of ILI visits to each setting
Community-based care
settings* (N = 4233,782)
Hospital emergency
department (N = 868,072)
<2 year 0.10 0.14
2–4 year 0.12 0.12
5–12 year 0.13 0.11
13–17 year 0.04 0.04
18–39 year 0.23 0.21
40–64 year 0.25 0.20
P65 year 0.14 0.19
Total 1.00 1.00
Abbreviation: ILI, inﬂuenza-like illness.
* i.e. Private ofﬁces, private clinics and local community health and social services
centers.
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at all lags and for the ﬁnal ARIMA models chosen for each subset.
While visits by adults and visits to EDs tended to be more strongly
correlated with P&I hospitalizations, pediatric visits and visits to
community settings most often correlated with P&I hospitaliza-
tions at earlier lags.3.2.1. Overall analysis
If lead time is deﬁned by the lag at which the maximum corre-
lation occurs in the CCF, then ILI visits aggregated across all age-
groups and settings provided no lead over P&I hospitalizations.
When restricted to community-based settings however, ILI visits
provided lead times that were equivalent to or greater than the
lead times provided by the ED visits for every age-group (Table 2).
ILI visits by children aged 2–17 years old to community settings
were most strongly correlated with P&I hospitalizations at the
greatest lags. The greatest lag at which a peak correlation occurred
was 2 weeks, although for certain age-groups, smaller yet still sig-
niﬁcant correlations occurred at a lag of 3 weeks as well. For exam-
ple, the heat-map of the CCFs for the overall analysis (Fig. 2) shows
that visits by 5–12 year olds to community settings were mostTable 2
A summary of key correlations and the lag at which they occur in the cross-correlation func
common reference time series of pneumonia and inﬂuenza hospitalizations during 1998–
Subset Peak correlation
Setting Age-group Lag (weeks)
Overall
Both setting types All ages 0
By visit setting
Community-based settings All ages 1
Emergency departments All ages 0
By age-group
Community-based settings <2 year 1
2–4 year 2
5–12 year 2
13–17 year 2
18–39 year 1
40–64 year 0
P65 year 0
Emergency departments <2 year 0
2–4 year 0
5–12 year 2
13–17 year 2
18–39 year 0
40–64 year 0
P65 year 0
* All correlations shown here were signiﬁcant (a = 0.05).
 i.e. Private ofﬁces, private clinics and local community health and social services centstrongly correlated with P&I hospitalizations at the 2 week lag,
but at the 3 week lag, ILI visits by 13–17 year olds to community
settings showed the strongest standardized correlation with P&I
hospitalizations.3.2.2. Year-to-year analysis
The CCFs from the year-to-year analysis showed that correla-
tions between outpatient ILI visits and P&I hospitalizations varied
widely between different epidemic periods (Table A-6 in the
appendix, and heat-maps in Fig. 3). The overall utility of ED visit
data in terms of timeliness and strength of correlation are compa-
rable to that of community settings in three seasons, better in one
season (1998–1999) but worse in another (2001–2002). The set-
tings and age-groups that were consistently correlated with P&I
hospitalizations with the greatest lead time were community set-
ting visits by 13–17 year olds and ED visits by 5–12 year olds
(Table 3).
With subsets demonstrating at best a 2 week lead in most sea-
sons, the 2001–2002 season was particularly distinctive for the
3 week lead for community setting visits by those aged <2, 2–4,
and 13–17 years. The peak correlations for those aged 5–12, and
18–39 years occurred at the same lag but they fell just below sta-
tistical signiﬁcance (a = 0.05). Even adults aged 40–64 years, unlike
any other season, had a peak correlation at the 1 week lag.4. Discussion
Using physician billing claims from outpatient care, we found
that visits to community-based clinics ILI tended to increase in fre-
quency earlier than visits to EDs. We also found that, relative to
adults or the elderly, increases in the number of ILI visits by chil-
dren provided the earliest signal of an epidemic. When considering
both visit setting and age, community setting visits for ILI by chil-
dren aged 2–17 years provided the greatest lead times over P&I
hospitalizations. Overall, community setting visits by children
aged 5–12 years stood out in particular due to the high peak corre-
lation with P&I hospitalizations, although community-setting visits
by children aged 13–17 years also exhibited a signiﬁcant correla-
tion at a greater lag compared to other subpopulations. Thesetions between time series of subsets of medical visits for inﬂuenza-like illnesses, and a
2003 in Quebec, Canada.
Earliest signiﬁcant correlation
Correlation* Lag (weeks) Correlation*
0.29 3 0.12
0.25 3 0.13
0.45 2 0.26
0.25 2 0.21
0.25 3 0.13
0.32 2 0.32
0.24 3 0.17
0.34 2 0.16
0.31 2 0.12
0.31 1 0.17
0.29 1 0.18
0.29 2 0.22
0.19 3 0.12
0.19 2 0.19
0.34 2 0.18
0.48 1 0.27
0.57 2 0.14
ers.
Table 3
For each inﬂuenza epidemic period during 1998–2003, a cross-correlation function was computed between various age-group and setting-speciﬁc subsets of inﬂuenza-like illness
visits, and a common reference time series of pneumonia and inﬂuenza hospitalizations in Quebec, Canada. This table shows selected subsets that demonstrated the greatest ‘‘lead
times’’ based on (1) the peak correlation and (2) the earliest signiﬁcant correlation (not necessarily peak) for each epidemic period. The subset that demonstrated the greatest
correlation for each column and epidemic period is bolded.
Subset Peak correlation Earliest signiﬁcant correlation
Setting Age-group Lag (weeks) Correlation* Lag (weeks) Correlation*
1998–1999
Emergency department 2–4 year 2 0.63 3 0.57
Emergency department 5–12 year 3 0.47 3 0.47
1999–2000
Community-based setting <2 year 1 0.65 2 0.43
Community-based setting 13–17 year 2 0.38 2 0.38
Emergency department 18–39 year 0 0.54 2 0.45
2000–2001
Community-based setting 2–4 year 2 0.59 2 0.59
Community-based setting 5–12 year 2 0.75 2 0.75
Emergency department 2–4 year 0 0.66 2 0.58
Emergency department 5–12 year 0 0.58 2 0.55
2001–2002
Community-based setting <2 year 3 0.50 3 0.50
Community-based setting 2–4 year 2,3 0.50 3 0.50
Community-based setting 13–17 year 3 0.40 3 0.40
2002–2003
Community-based setting 5–12 year 2 0.41 2 0.41
Community-based setting 13–17 year 2 0.72 2 0.72
Emergency department 5–12 year 2 0.45 2 0.45
Emergency department 13–17 year 2 0.57 2 0.57
* All correlations shown were signiﬁcant (a = 0.05).
 Correlation at lags of 2 and 3 weeks were the same.
Lag (weeks)
Ag
e 
gr
ou
p
>= 65 y
40−64 y
18−39 y
13−17 y
5−12 y
2−4 y
< 2 y
All ages
0 1 2 3 4
Emergency department
>= 65 y
40−64 y
18−39 y
13−17 y
5−12 y
2−4 y
< 2 y
All ages
Community−based setting
−1.5
−1.0
−0.5
0.0
0.5
1.0
1.5
R
ow
−standardized correlation 
Fig. 2. A heat-map representation of the cross-correlation functions between time
series of subsets of medical visits for inﬂuenza-like illness by age-group to two
types of outpatient settings, and a common reference time series of pneumonia and
inﬂuenza hospitalizations in Quebec, Canada for all weeks from 1998 through 2003.
Correlations are represented on a color gradient after having been standardized to
each subset (row). Dots indicate correlations that were signiﬁcant (a = 0.05).
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of ILI as they identify potential targets to monitor as sentinels of an
oncoming inﬂuenza epidemic.
One reason for the earlier timing of ILI visits in community set-
tings compared to the ED may be that the symptoms in the early
stages of illness are mild enough that community-based care
would be sought ﬁrst over ED care [29]. However, the majority of
those who have evaluated the potential utility of a particular data
source for syndromic surveillance of inﬂuenza have focused on the
ED [14–16,30], and few have looked at community-based settings
[31–34]. The predominance of ED-based studies is probably due to
the fact that, especially in the United States, many of the already
existing syndromic surveillance systems for inﬂuenza are based
on ED data, such as chief complaints and discharge diagnoses,
which are more easily obtainable compared to data from other set-
tings. To our knowledge, only one study [13] has compared these
two setting types, but data were drawn from several different pop-
ulations. Using a single source population avoids potential con-
founding due to population differences in, for example,
socioeconomic status or healthcare utilization behavior. Further-
more, that the province’s universal health insurance program cov-
ers 99% of all residents in our study location, and that this allowed
us complete ascertainment of healthcare delivered on a fee-for-
service basis for our patient study population presented us an
opportunity to conduct a population-wide study that would not
be easily possible in other locations such as the United States,
and demonstrates the capacity of the Canadian universal health
insurance programs for providing data to conduct such popula-
tion-wide studies.
Our results for children are not surprising given that children
have undeveloped immune systems that render them susceptible
to inﬂuenza infection. They have the second highest rate of excess
hospitalizations for P&I, after the elderly, and the highest rates of
excess physician visits and ED visits for P&I (excess deﬁned as be-
yond non-epidemic period baseline) [1].
Inﬂuenza morbidity is generally higher among younger children
than for older children [2], but our results point to ILI visits from
1998−1999, N=21
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Fig. 3. A heat-map representation of the cross-correlation functions between each inﬂuenza-like illness visits time series subset by age-group and type of visit setting, against
a common reference time series of pneumonia and inﬂuenza hospitalizations in Quebec, Canada for each epidemic period during 1998–2003. Correlations are represented on
a colour gradient after having been standardized to each subset. Dots indicate correlations that were signiﬁcant (a = 0.05). N = number of weeks included for each inﬂuenza
season.
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indicators of an inﬂuenza epidemic, which is consistent with their
role as the primary vectors of inﬂuenza transmission in a popula-
tion [35–38]. Their efﬁciency as spreaders of inﬂuenza may result
from an interplay between both their innate ability to shed the
virus earlier and for a longer time than adults [39,40], and their
more extensive social contact patterns compared to younger in-
fants [41,42]. In response to recent studies, for the 2008–2009 sea-
son, the Advisory Committee on Immunization Practices (ACIP) of
the Centers for Disease Control and Prevention (CDC) in the United
States updated their recommended target groups for annual vacci-
nation to all children aged 6 months to 18 years [43]. Previously,
among healthy children, the ACIP targeted only those aged
6 months to 4 years. Canada has not yet adopted this expanded
vaccination policy [44].
Our ﬁndings, suggesting that pediatric age-groups act as a sen-
tinel population for inﬂuenza within administrative data are con-
sistent with other studies [2,13–15], although the exact age
range is in dispute. Two other studies [2,14] identiﬁed school-aged
children as sentinels, as we did, but others have pointed to slightly
younger age-groups such as 3–4 years [13] and under 5 years [15].
However, we also found a degree of year-to-year variation in
our results. Year-to-year variation may contribute to the reason
why different pediatric age-groups have been identiﬁed as sentinel
populations for inﬂuenza across different studies covering different
study periods. The lack of consistently early rises in visits in spe-
ciﬁc age-groups and settings has important implications for setting
and age-group focused inﬂuenza surveillance. This ﬁnding also
suggests that it will be difﬁcult to construct accurate age-speciﬁc
statistical forecasting models because such models require stable
indicators of the onset or peak of an outbreak [45].
This year-to-year variation in the age-groups and settings with
the earliest rise in visits may be a consequence of the constant evo-
lution of the inﬂuenza virus that results in the regular emergence
of new strains. If the mutation rate is fast, herd immunity is de-
creased as fewer individuals will have had the opportunity to gain
immunity to circulating strains through exposure. A/H3N2 viruses
are believed to have faster rates of antigenic mutation (antigenic
drift) than A/H1N1 and B viruses [46]. It is for this reason that years
predominated by A/H3N2 strains are associated with more severe
epidemics, especially for young children and the elderly [47–49].During the 1998–1999 season, an A/H3N2 strain was the predom-
inant strain in circulation, and we found that ILI visits to the ED
were signiﬁcantly correlated with P&I hospitalizations at lags of
1 week or more for all age-groups except those <2 years. On the
other hand, no community setting subset provided any lead during
this season. In contrast, for the 2000–2001 season, during which no
laboratory-conﬁrmed cases of subtype A/H3N2 were reported in
Quebec [50], no ED subset provided any lead. Since the ED typically
sees more severe cases than community settings, the contrast in
lead times may reﬂect heavier ED utilization during the more se-
vere A/H3N2 seasons.
A relationship between age and inﬂuenza subtype has been
established as well. Fox et al. found that young school children
(5–9 years) had the highest infection rates and were the main
introducers of inﬂuenza during A/H3N2 seasons, but implicated
teenagers (10–19 years) during A/H1N1 and B seasons [35,51]. An-
other study pointed to younger age-groups: those aged 1–4 years
during type A outbreaks and those aged 5–9 years during mixed
or type B outbreaks [52]. In our study, community visits by 13–
17 year olds provided the earliest leads in two of the three A/
H3N2 predominant seasons (1999–2000, 2001–2002). In contrast,
community visits by 5–12 year olds provided the best lead during
the single A/H1N1 and B predominant season (2000–2001) in our
study period. While these age–strain interactions are worthy of
further investigation, the variation in the ﬁndings across these dif-
ferent studies and the small number of inﬂuenza seasons examined
means deﬁnitive conclusions about the dependence of timeliness
on age and inﬂuenza subtype cannot be made.
Reﬂecting the link between age and immunity, when a strain re-
emerges after a long absence, children will often be particularly
vulnerable to infection, unlike adults whomay already have immu-
nity if the strain last circulated within their life time. Furthermore,
a vaccine mismatch usually occurs for these seasons. The 2001–
2002 season, when a B/Victoria-lineage virus re-emerged for the
ﬁrst time in a decade in North America [53], was particularly se-
vere, especially for school-aged children, and ED visits [14]. Simi-
larly, the emergence of a novel A/H1N1 inﬂuenza strain in 2009
disproportionately affected children and young adults, with many
school-based outbreaks [54–57], as is characteristic of pandemic
inﬂuenza [58]. Our results for the 2001–2002 season demonstrate
the impact of a re-emerged strain on the timing of ILI visits by
E.H. Chan et al. / Journal of Biomedical Informatics 44 (2011) 221–228 227children to community settings as well. For our study location
(Quebec), the B/Victoria lineage had last been identiﬁed during
the 1988–1989 season [59]. Therefore it would be expected that
most of the younger children (<13 years) had no or limited immu-
nity. Among community setting subsets, we found a remarkable
3 week lead for most of the pediatric age-groups during this sea-
son. However, no lead was observed for the two oldest age-groups
(40–64 and P65 years), consistent with their presumed prior
immunity to this lineage.
Although a year-by-year analysis may not always be helpful in
deciding which subgroup may be most likely to provide the stron-
gest and earliest signals for inﬂuenza surveillance each year, this
approach may nonetheless be a beneﬁcial complement to an over-
all analysis, as the yearly variation observed in this and other stud-
ies suggests [15,16,60]. Analyzing yearly variations may prevent
inappropriate generalizations or reveal patterns underlying differ-
ent years with common traits.
There are some limitations to our study. Respiratory syncytial
virus (RSV) is another major viral respiratory pathogen whose
impact exceeds that of inﬂuenza among young children [61]
and the elderly [62]. We could not distinguish RSV from inﬂu-
enza since RSV is clinically similar to and often co-circulates with
inﬂuenza [63]. More broadly, misclassiﬁcation bias (misdiagnosis
or errors in coding) is a chief limitation in the use of ICD-9 coded
billing data compared to laboratory conﬁrmed diagnoses. The
patterns in our time series of ILI visits may reﬂect a combination
of the patterns of both inﬂuenza and RSV, which could diminish
the correlation between the ILI visits time series and the P&I hos-
pitalizations time series. However, RSV mainly affects the very
young, and we used an ILI code set that has been validated
against inﬂuenza viral isolates [31]. We also acknowledge that
our epidemic period deﬁnition is unveriﬁed, but there has been
no consistent deﬁnition and a variety of approaches have been
used [1,15,60]. We tried other slight variations in the epidemic
period deﬁnition with little impact on the results. With only ﬁve
inﬂuenza seasons’ worth of data, it is also difﬁcult to make gen-
eralizations for speciﬁc inﬂuenza subtypes. Finally, while we ar-
gue for the utility of these real-time or near real-time data for
surveillance, we should also note that it may be difﬁcult to get
similar data in real-time or near real-time in the United States
and other locations. While we have looked at syndromic data
only in this study, it would also be important to also conduct a
separate comparison of the value of traditional ‘‘pen and paper’’
sentinel clinic site surveillance to that of electronic automated
syndromic surveillance for ILI to validate the advantages of one
over the other.
5. Conclusion
Across 6 years, medical visits by school-aged children to com-
munity clinics provided the earliest indication of the onset of an
inﬂuenza epidemic. Separate analysis of each inﬂuenza season re-
vealed that ILI syndromic surveillance should not focus on any sin-
gle subgroup but a combination of several age-group and visit
setting speciﬁc subgroups. Due to region-speciﬁc differences in
healthcare seeking behaviors, we recommend that our ﬁndings
be replicated for different regions. This study demonstrates the
ﬂexibility of automated syndromic surveillance for monitoring
real-time data as it allows for the rapid identiﬁcation of age and
setting epidemiological patterns in the data. This kind of insight
is important for both seasonal inﬂuenza and for novel and rapidly
evolving outbreaks that emerge unexpectedly and for which the
epidemiological proﬁle is unknown. A better understanding of
these relationships would help improve the accuracy of infectious
disease surveillance systems, and enable the prompt initiation and
evaluation of appropriate public health interventions.Acknowledgments
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